What is UroGen Pharma's current ratio?

UroGen Pharma (URGN) reported current ratio of 4.7× in Q1 2026.

How has UroGen Pharma's current ratio changed year-over-year?

UroGen Pharma's current ratio decreased by 17.0% year-over-year, from 5.6× to 4.7×.

What is the long-term trend for UroGen Pharma's current ratio?

Over 5 years (2020 to 2025), UroGen Pharma's current ratio has grown at a -5.8% compound annual growth rate (CAGR), from 5.4× to 4×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

UroGen Pharma URGN Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.4×+0.1×

PfizerPFE

1.2×0.0×

Johnson & JohnsonJNJ

1×-0.2×

Merck & Co.MRK

1.3×-0.1×

ImmunityBio, Inc.IBRX

6.7×+4.4×

Tyra Biosciences, Inc.TYRA

20.5×-2.3×

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.71B+71.7%

Enterprise value$1.8B+80.9%

P/S12.2×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Where this comes from

Calculated from UroGen Pharma’s reported figures.

total current assets/total current liabilities=4.7×

Based on the most recent quarter.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's current ratio?: UroGen Pharma (URGN) reported current ratio of 4.7× in Q1 2026.
How has UroGen Pharma's current ratio changed year-over-year?: UroGen Pharma's current ratio decreased by 17.0% year-over-year, from 5.6× to 4.7×.
What is the long-term trend for UroGen Pharma's current ratio?: Over 5 years (2020 to 2025), UroGen Pharma's current ratio has grown at a -5.8% compound annual growth rate (CAGR), from 5.4× to 4×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.